Cited by 52Ion channel regulation and functionAnesthesia and Sedative AgentsCardiac electrophysiology and arrhythmias

Malignant Hyperthermia: A Pharmacogenetic Disorder

Stowell, Kathryn M·2008·Pharmacogenomics

Abstract

Malignant hyperthermia (MH) is a pharmacogenetic disorder triggered by volatile anesthetics or depolarizing muscle relaxants in predisposed individuals. Exercise or stress-induced MH episodes, in the absence of any obvious pharmacological trigger, have been reported, but these are rare. A considerable effort has taken place over the last two decades to identify mutations associated with MH and characterize their functional effects. A number of different, but complementary systems, have been developed and implemented to this end. The results of such studies have identified commonalities in functional affects of mutations, and also uncovered unexpected complexities in both the structure and function of the skeletal muscle calcium-release channel. The following review is an attempt to provide a summary of the background to current MH research, and highlight some recent advances in our knowledge of the molecular basis of the phenotypic expression of this disorder.

Integrity signals

Registry

Crossref · 10.2217/14622416.9.11.1657

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Indirect evidence from malignant hyperthermia and mild cold exposure in humans suggest that muscle NST mechanisms may exist.

    “Clearly, indirect evidence from malignant hyperthermia 44 and mild cold exposure in humans 45 suggest that such mechanisms may exist and that further investigation of this area is warranted.”

    From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [44]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stowell, K. M.
Affiliations
Massey University (NZ)
Corresponding author
Stowell, Kathryn M
Venue
Pharmacogenomics
Published
2008-11
Volume
9
Issue
11
Pages
1657-1672
ISSN
  • 1462-2416 (ISSN-L)
  • 1744-8042
OpenAlex
W1982091952
Cited by
52
References
135
Citations by year
2024: 1 · 2022: 1 · 2021: 1 · 2020: 5 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 4 · 2013: 9 · 2012: 7
FWCI
0.31
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacogenomics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
malignant hyperthermia, pharmacogenetics, skeletal muscle ryanodine receptor, RYR1 mutations, calcium release channel, volatile anesthetics, depolarizing muscle relaxants, molecular basis of disease
MeSH terms
Animals, Calcium, Humans, Malignant Hyperthermia, Muscle Relaxants, Central, Myocardium, Pharmacogenetics, Muscle, Skeletal, Ryanodine Receptor Calcium Release Channel, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review